Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model
Alyssa Siefert, Allison Ehrlich, María Jesús Corral, et al.
Biomaterials (2016) Vol. 108, pp. 168-176
Open Access | Times Cited: 19

Showing 19 citing articles:

Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines
Jiemin Wang, Xiong-Bin Hu, Daxiong Xiang
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 1319-1327
Open Access | Times Cited: 108
Nanoparticles: New agents toward treatment of leishmaniasis
Amirhossein Nafari, Koroush Cheraghipour, Maryam Sepahvand, et al.
Parasite Epidemiology and Control (2020) Vol. 10, pp. e00156-e00156
Open Access | Times Cited: 82
Promising nanotherapy in treating leishmaniasis
Aline de Souza, Débora Soares Souza Marins, Samir Leite Mathias, et al.
International Journal of Pharmaceutics (2018) Vol. 547, Iss. 1-2, pp. 421-431
Open Access | Times Cited: 80
Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis
Andrea Lafleur, Stephane Daffis, Charles E. Mowbray, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1179-1179
Open Access | Times Cited: 5
Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses
Mahboubeh Ebrahimian, Maryam Hashemi, Mohsen Maleki, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 48
Nanomaterials for direct and indirect immunomodulation: A review of applications
Jana Kubackova, Jarmila Zbytovská, Ondřej Holas
European Journal of Pharmaceutical Sciences (2019) Vol. 142, pp. 105139-105139
Closed Access | Times Cited: 36
The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis
Zahra Abpeikar, Mohsen Safaei, Ali Alizadeh, et al.
International Journal of Pharmaceutics (2023) Vol. 633, pp. 122615-122615
Closed Access | Times Cited: 11
Encapsulation of Citrus sinensis essential oil and R-limonene in lipid nanocarriers: A potential strategy for the treatment of leishmaniasis
Jeferson da Silva dos Santos, Juliana Gouveia Galvão, Marcos Rafael das Chagas Mendonça, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124464-124464
Closed Access | Times Cited: 4
Mechanisms of hydrogel-based microRNA delivery systems and its application strategies in targeting inflammatory diseases
Shaorun Hu, Liang Yu, Jinxiang Chen, et al.
Journal of Tissue Engineering (2024) Vol. 15
Open Access | Times Cited: 4
Envisioning the Innovations in Nanomedicine to Combat Visceral Leishmaniasis: For Future Theranostic Application
Om Prakash Singh, Mallikarjuna Rao Gedda, Shyam Lal Mudavath, et al.
Nanomedicine (2019) Vol. 14, Iss. 14, pp. 1911-1927
Open Access | Times Cited: 33
Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis
Olga Kammona, Evgenia Tsanaktsidou
International Journal of Pharmaceutics (2021) Vol. 605, pp. 120761-120761
Closed Access | Times Cited: 24
Emerging strategies and challenges of molecular therapeutics in antileishmanial drug development
Deepak Gupta, Pankaj Kumar Singh, Pavan Kumar Yadav, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109649-109649
Closed Access | Times Cited: 9
Inhibition of cow’s milk allergy development in mice by oral delivery of β‐lactoglobulin‐derived peptides loaded PLGA nanoparticles is associated with systemic whey‐specific immune silencing
Mengshan Liu, Suzan Thijssen, Cornelus F. van Nostrum, et al.
Clinical & Experimental Allergy (2021) Vol. 52, Iss. 1, pp. 137-148
Open Access | Times Cited: 15
A Mouse Model of Ulcerative Cutaneous Leishmaniasis by Leishmania (Viannia) panamensis to Investigate Infection, Pathogenesis, Immunity, and Therapeutics
Natalia Muñoz‐Durango, Alexander Gómez, Natalia García-Valencia, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 6
Antiparasitic Activity of Nanomaterials
A. Najitha Banu, Natasha Kudesia, Neha Rana, et al.
(2023), pp. 173-205
Closed Access | Times Cited: 1
Anti-leishmanial therapies: overcoming current challenges with emerging therapies
Shyam Sundar, Prasoon Madhukar, Rajiv Kumar
Expert Review of Anti-infective Therapy (2024)
Closed Access
Hyaluronic acid–amphotericin B nanocomplexes: a promising anti-leishmanial drug delivery system
Ricardo Silva-Carvalho, Teresa Leão, Ana I. Bourbon, et al.
Biomaterials Science (2022) Vol. 10, Iss. 8, pp. 1952-1967
Closed Access | Times Cited: 2
Early life cow's milk allergy prevention
Mengshan Liu
(2023)
Open Access
Nanoformulations for new compounds against leishmaniasis
Sandra Elisa Haas, Tamara Ramos Maciel, Marcelo Gomes de Gomes
Elsevier eBooks (2021), pp. 243-252
Closed Access
Page 1

Scroll to top